A sophisticated sovereign wealth fund with major global holdings selected GroveStreet as its partner in venture stage technology.

GroveStreet’s Solution:

  • GroveStreet built and cultivates a core pool of venture relationships covering TMT and life sciences including established and emerging teams in the US, Europe, and Asia.
  • The platform is designed to provide early identification of segments that can provide attractive returns and that may disrupt the client’s existing holdings.
  • We collaborate with the client’s in-house industry teams which span private and public markets to identify direct deal opportunities with a view to scaled follow-on investments at IPO and beyond.
  • Since 2012, GroveStreet has been entrusted with $700 million plus associated direct investments held in a separate pool.